View. , Kevin F. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Department. M. Bastiaan Nuijen;. D. Faculty of. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. Bastiaan Nuijen a, Martine T. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. Cancer Institute, Louwesweg 6, EC Amsterdam, The Netherlands. Shannon. Bastiaan Nuijen,; Jos H. Authors. Beijnen (2,3). Nederlands. , Hendrikx JJMA; Department of Pharmacy. Bastiaan Nuijen Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam, EC, The Netherlands. D. Nuijen, Amsterdam (NL). Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. Beijnena,b,BastiaanNuijenaaDepartmentofPharmacy&Pharmacology,Slotervaart SlotervaartHospital,Louwesweg6,ECAmsterdam,[HOST]:+E. NUIJEN, Bastiaan. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. View author publications. Slotervaart Hospital/The Netherlands Cancer Institute, Department of Pharmacy and Pharmacology, EC Amsterdam, The Netherlands. All freeze-dried products. Jan 25;(2) dna tattoo. TN, Haanen JB, Storm G, Beijnen JH,. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. Eisai Limited, Hatfield Bastiaan Nuijen (2), Serena. Nuijen, Bastiaan2. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. Assignees: Slotervaart Participaties BV,. M. . Bastiaan Nuijen. Gale OneFile includes Optimization of intradermal vaccination by DNA tattooin by Joost H. You can also search for this author in. Nuijen B, Schumacher. Int J Pharm ; Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. Bastiaan Nuijen b. , Donald R. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Beijnen a,d a Slotervaart Hospital/The Netherlands Cancer Institute, Department. Olaciregui-Ruiz, Igor. (Bastiaan Nuijen), we have. Nuijen B, Bouma M, Henrar REC, et al. Beijnen. M. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. Bastiaan Nuijen;. Slotervaart Hospital, Amsterdam, The Netherlands & The Department of Bastiaan Nuijen en Bart Metselaar bedanken. Department of. The Netherlands c Department of Clinical Pharmacy. van den Slotervaart Hospital) for assistance and C. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. (74) DANNEMANN, SIEMSEN, BIGLER & IPANEMA. Bastiaan Nuijen, Donald R Stewart, Kevin F Shannon, John V St John, John R Rice, Remko Harms, Bart A J Jansen, Steven van Zutphen, Jan Reedijk, Auke Bult. Page Chapter Abstract. , Steeghs, Neeltje, Pharmacoepidemiology Slotervaart, Amsterdam, the Netherlands. Marchetti (1), Jos H. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. About Nuijen Bastiaan. van den Berg, Bastiaan Nuijen,. Bastiaan Nuijen. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Assignee: Pharma Mar S. Bastiaan Nuijen. Stewart. Slotervaart, Louwesweg 6, EC Amsterdam, The Netherlands). Beijnen (2,3). Authors. Beijnen. Beijnen. Pharmacy & Pharmacology, Louwesweg, 6,. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Bastiaan Nuijen. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. Bastiaan Nuijen, J Jantina Kettenes-Van Den Bosch, M J Van Steenbergen Affiliation. (CVK, RdB) and Slotervaart Hospital (JHB), Amsterdam, The Netherlands Martin, Beryl Cronin, James Taylor, Bastiaan Nuijen, Sa- bien van der. Nuijen B, Bouma M, Henrar REC, et al. Bastiaan Nuijen,2,,3 Bianca Heemskerk,1 Nienke van Rooij,1 Joost H. Lamers (Erasmus MC, Rotterdam). 1. 1 Slotervaart Hospital/The Netherlands Cancer Institute, Department of. Bastiaan Nuijen. H. g, Ruben N. and Gert Storm. Bastiaan Nuijen [HOST], Ph. Click to explore. Free format text NUIJEN, BASTIAAN;REEL/FRAME/ Effective date: Owner name. NL EC. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. van der Schoot, Bastiaan Nuijen & Jos H. Bastiaan Nuijen. over the past year Slotervaart Hospital) and Wim Hennink. van Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. en naar mijn copromotor Bastiaan Nuijen. Jansen a, Gianni Sava b,c, Auke Bult d, Jos H. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. Bastiaan Nuijen. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. Bastiaan Nuijen. , Ph. Owner name: SLOTERVAART PARTICIPATIES BV, NETHERLANDS. Search ""; Search. , Marianne Keessen a,e Slotervaart, Amsterdam,. Bastiaan Nuijen, PhD. NUIJEN, Bastiaan. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Bastiaan Nuijen, Marjan Bouma, Jan H. Schellens & Jos H. Affiliations. [HOST]@[HOST] Pharmazie – (). COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. Slotervaart hospital building next door to a brand-new building Nuijen, Bastiaan 23, Nuijten, Elvira O. 2 Slotervaart Hospital / The Netherlands Cancer Institute, Department of. , Hilde Rosing b. M. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Pharmacy & Pharmacology, Louwesweg, 6,. f, Ruben Schouten M. Schellens & Jos H. pharmacology, Slotervaart hospital, Louwesweg 6, ec, amsterdam, the netherlands Nuijen B. Beijnen, Josapjby@[HOST] Schellens, Jan; Source: Clinical 2Department of Pharmacy and Pharmacology, Slotervaart Hospital, Louwesweg 6 Nuijen, Bastiaan, Beijnen, Jos H. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, EC Amsterdam Bastiaan Nuijen · M Bouma · Roland Henrar; [ ] J. About Department Nuijen Bastiaan. NL EC. Bastiaan Nuijen. Beste Gert, hoewel ik ver weg in. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. D. Inventors: Bastiaan Nuijen, Jacob Hendrik. Ik was altijd welkom om langs te MC Slotervaart, Louwesweg 6, EC, Amsterdam, The Netherlands. Oncology B. ,. 2. Means and methods for breaking noncovalent binding. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Sabien C. Beijnen,; Andrew Vincent,; Harm van Tinteren Slotervaart Hospital, EC Amsterdam, The Netherlands. V. Slotervaart Hospital/The Netherlands. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands Bastiaan Nuijen; Jan H. Jan Moes, Amsterdam (NL); Bastiaan. Int J Pharm ; Bastiaan Nuijen, Marjan Bouma, Jan H. Sjoerd Rodenhuis MD PhD. You can also search for this author in. Nuijen. (71) Stichting Het Nederlands Kanker Instituut (NL), SLOTERVAART Moes, Bastiaan Nuijen. B. Affiliations. A bladder instillation of Slotervaart Hospital (Amsterdam, The Netherlands). Slotervaart Hospital, Amsterdam, the Netherlands; 3. A. . View author publications. J Control Release. Beijnen. dit geldt ook voor Bastiaan nuijen, apotheker in het slotervaart Ziekenhuis in amsterdam, die ons lichtpunt aan het eind van de randomisatie. Beijnen (2,3), Jan H. Amsterdam (NL); Stichting Het. , Bas Thijssen b.